No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis
P. V. Gejman, A. Ram, J. Gelernter, E. Friedman, Q. Cao, D. Pickar, K. Blum, E. P. Noble, H. R. Kranzler, S. O'Malley and al. et
Clinical Neurogenetics Branch, National Institute of Mental Health, Bethesda, Md. 20892.
OBJECTIVE--To examine the dopamine D2 receptor (DRD2) gene coding sequences
for abnormalities associated with schizophrenia or alcoholism and thereby
help to resolve the controversy surrounding the reported association of
alcoholism with a restriction fragment length polymorphism located close to
the DRD2 gene. DESIGN--Mutational analysis of complete DRD2 gene coding
sequences by denaturing gradient gel electrophoresis followed by direct
nucleotide sequencing of detected variants. SETTING--Patients and controls
from clinical and epidemiologic collections in the United States and
Europe. PATIENTS--A total of 253 unrelated individuals, including 106
patients with schizophrenia, 113 with alcoholism, and 34 controls. For
alcoholism we included patients from previously published series in which
an association of illness with allele A1 was reported (Taql site 3' to the
DRD2 gene) and from other published series in which nonconfirmations of
this association were reported. Nearly all persons examined were white.
MAIN OUTCOME MEASURES--Frequency of nonsilent variations in DRD2 gene DNA
sequences in the different diagnostic groups. RESULTS--We found three
infrequent DNA variants that predict altered amino acid sequence of the
receptor. None of these is associated with either alcoholism or
schizophrenia. CONCLUSION--No structural coding abnormalities in the DRD2
gene are present in alcoholism or schizophrenia.
Pharmacogenetics of Psychotropic Drug Response
Malhotra et al.
Am. J. Psychiatry 2004;161:780-796.
ABSTRACT
| FULL TEXT
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
Duan et al.
Hum Mol Genet 2003;12:205-216.
ABSTRACT
| FULL TEXT
Influential Ideas and Experimental Progress in Schizophrenia Genetics Research
Sanders and Gejman
JAMA 2001;285:2831-2833.
FULL TEXT
A Ser311Cys Mutation in the Human Dopamine Receptor D2 Gene Is Associated With Reduced Energy Expenditure
Tataranni et al.
Diabetes 2001;50:901-904.
ABSTRACT
| FULL TEXT
Neurochemical Individuality: Genetic Diversity Among Human Dopamine and Serotonin Receptors and Transporters
Cravchik and Goldman
Arch Gen Psychiatry 2000;57:1105-1114.
ABSTRACT
| FULL TEXT
ALCOHOLICS WITH THE DOPAMINE RECEPTOR DRD2 A1 ALLELE HAVE LOWER PLATELET MONOAMINE OXIDASE-B ACTIVITY THAN THOSE WITH THE A2 ALLELE: A PRELIMINARY STUDY
Eriksson et al.
Alcohol Alcohol 2000;35:493-498.
ABSTRACT
| FULL TEXT
Association of a missense change in the D2 dopamine receptor with myoclonus dystonia
Klein et al.
Proc. Natl. Acad. Sci. USA 1999;96:5173-5176.
ABSTRACT
| FULL TEXT
Modification of Alcohol Withdrawal by the A9 Allele of the Dopamine Transporter Gene
Schmidt et al.
Am. J. Psychiatry 1998;155:474-478.
ABSTRACT
| FULL TEXT
Functional Analysis of the Human D2 Dopamine Receptor Missense Variants
Cravchik et al.
J. Biol. Chem. 1996;271:26013-26017.
ABSTRACT
| FULL TEXT
Medical Disorders of Alcoholism
Lieber
NEJM 1995;333:1058-1065.
FULL TEXT